OraSure Technologies, Inc. amended its 8-K filing on December 19, 2024, to provide financial details regarding its acquisition of Sherlock Biosciences, made official on the same date. The filed pro forma financial information outlines the combined results for the companies as of January 1, 2024, and is for informational purposes only.